GeneDx Earnings
NASDAQ: WGSHealth CareMedical/Nursing ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Tue, Oct 27, 2026
Fiscal period
Sep/2026
EPS estimate
$0.07
GeneDx earnings summary
GeneDx is scheduled to report Sep/2026 earnings on Oct 27, 2026, with analysts expecting EPS of $0.07. In its most recent report on Aug 3, 2026 (Q2 2026), WGS posted EPS of $-0.60. Revenue for the quarter was $114.4 million.
Quarterly EPS is down 266.7% from the same quarter a year earlier. Across the last 16 reports, WGS shares moved an average of 8.2% (in either direction) in the first trading session after results, rising 9 times and falling 7 times.
Summary generated from market data by MetaCap's automated system. Methodology
WGS earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 3, 2026 | — | $-0.60 | — | +1.3% |
| May 4, 2026 | — | $-2.16 | — | -0.0% |
| Feb 23, 2026 | — | $-0.59 | — | +10.5% |
| Oct 28, 2025 | — | $-0.27 | — | +2.1% |
| Jul 29, 2025 | — | $0.36 | — | +3.5% |
| Apr 30, 2025 | — | $-0.23 | — | -12.0% |
| Feb 20, 2025 | — | $0.25 | — | +7.3% |
| Oct 29, 2024 | — | $-0.31 | — | +0.1% |
| Jul 30, 2024 | — | $-1.10 | — | +8.9% |
| Apr 29, 2024 | — | $-0.78 | — | +5.5% |
| Feb 23, 2024 | — | $-0.71 | — | +8.1% |
| Nov 3, 2023 | — | $-1.64 | — | -30.2% |
| Aug 8, 2023 | — | $-1.84 | — | -8.0% |
| May 9, 2023 | — | $-3.04 | — | -5.7% |
| Mar 16, 2023 | — | $-28.15 | — | -9.0% |
| Nov 14, 2022 | — | $-6.72 | — | -18.5% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.